The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of cisplatin with or without S-1 in patients with FIGO IVB, recurrent, or persistent cervical cancer: An Asian study.
 
Soyi Lim
No Relationships to Disclose
 
Kazunori Ochiai
Consulting or Advisory Role - Taiho Pharmaceutical; Zeria Pharmaceutical
 
Yoichi Aoki
No Relationships to Disclose
 
Daisuke Aoki
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Shoji Kamiura
No Relationships to Disclose
 
Hao Lin
No Relationships to Disclose
 
Yasuhiro Fujiwara
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly
Research Funding - Chugai Pharma (Inst); Takeda (Inst)
 
Soon Do Cha
No Relationships to Disclose
 
Jae Hoon Kim
No Relationships to Disclose
 
Byoung Kim
No Relationships to Disclose
 
Yasuyuki Hirashima
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - Asahi Kasei; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Lilly Japan; Nippon Kayaku; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; MSD; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Young Tak Kim
No Relationships to Disclose
 
Seok-Mo Kim
No Relationships to Disclose
 
Hyun Hoon Chung
No Relationships to Disclose
 
Ting-Chang Chang
Patents, Royalties, Other Intellectual Property - Chang Gung Medical Foundation-Linkuo/ National Tsing Hua University (Inst)
 
Toshiharu Kamura
No Relationships to Disclose
 
Ken Takizawa
No Relationships to Disclose
 
Masahiro Takeuchi
Consulting or Advisory Role - Abbvie; AstraZeneca; Hisamitsu Pharmaceutical; Kowa; Kyorin; Mitsubishi Tanabe Pharma; Sanofi; Taiho Pharmaceutical; Takeda
 
Soon-Beom Kang
No Relationships to Disclose